Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer June 15, 2021
ASCO 2021: Addition of palbociclib to fulvestrant attains overall survival benefit in advanced breast cancer with update of PALOMA-3 June 15, 2021